Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights

Notice type: 3rd Party Publications

Date: 27/10/2017

 

Background Information Or Related Documents:

The Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines. Its recommendations are considered by the Committee for Medicinal Products for Human Use (CHMP) when it adopts opinions for centrally authorised medicines and referral procedures and by the Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) when it provides a recommendation on the use of a medicine in Member States. 

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 23-26 October 2017

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 25-29 September 2017

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 29 August - 1 September 2017

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3-6 July 2017

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 6-9 June 2017

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 2-5 May 2017

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3-6 April 2017

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 6-9 March 2017

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 6-9 February 2017

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 9-12 January 2017

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 28 November - 1 December 2016

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 24-27 October 2016

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 26-29 September 2016

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 30 August - 2 September 2016

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 4-8 July 2016

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 6-9 June 2016

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 10-13 May 2016

Pharmacovigilance Risk Asssessment Committee (PRAC) Meeting Highlights 11-14 April 2016

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 14-17 March 2016

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 8-11 February 2016

Pharmacovigilance Risk Asssessment Committee (PRAC) Meeting Highlights 11-14 January 2016

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 30 November - 3 December 2015

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3-5 November 2015
 
Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 5-8 October 2015

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 7-10 September 2015

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 6-9 July 2015

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 8-11 June 2015

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 4 -7 May 2015

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 7-10 April 2015
 
Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 9-12 March 2015 

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 9-12 February 2015
 
Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 6-9 January 2015

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 1-4 December 2014

Pharmacovigilance Risk Assessment Committed (PRAC) Meeting Highlights 3-6 November 2014

Pharmacovigilance Risk Assessment Committed (PRAC) Meeting Highlights 6-9 October 2014

Pharmacovigilance Risk Assessment Committed (PRAC) Meeting Highlights 8-11 September 2014 
 
Pharmacovigilance Risk Assessment Committed (PRAC) Meeting Highlights 7-10 July 2014

Pharmacovigilance Risk Assessment Committed (PRAC) Meeting Highlights 10-13 June 2014

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 5-8 May 2014

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 7-10 April 2014

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3-6 March 2014

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3-6 February 2014

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 6-9 January 2014

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 2-5 December 2013

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 4-7 November 2013

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 7-10 October 2013

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights  2-5 September 2013

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 8-11 July 2013

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 10-13 June 2013

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 13-16 May 2013

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 8-11 April 2013

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 4-7 March 2013

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 4-7 February 2013

Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 7-10 January 2013



« Back